FDA Approved: TRACLEER — Original Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

The FDA approved TRACLEER (bosentan) through its original application filed by Actelion Pharmaceuticals US, Inc. for the treatment of pulmonary arterial hyperte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• TRACLEER (bosentan)

Snippet

ORIG AP for TRACLEER (BOSENTAN)